Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.
暂无分享,去创建一个
Alexey Rivkin | Chaomin Li | A. Szewczak | J. Crispino | B. Muñoz | M. Shearman | Sean P Ahearn | Stephanie M Chichetti | Yoona R Kim | Andrew Rosenau | Sam D Kattar | Joon Jung | Sanjiv Shah | Bethany L Hughes | Jamie L Crispino | Richard E Middleton | Alexander A Szewczak | Benito Munoz | Mark S Shearman | Joon Jung | R. Middleton | Stephanie M. Chichetti | Chaomin Li | Sanjiv J. Shah | Sean P. Ahearn | A. Rivkin | Andrew Rosenau
[1] Chaomin Li,et al. A practical strategy for the synthesis of 2-dialkylamino-4-arylamino-6-aminopyrimidines , 2009 .
[2] D. Melton,et al. Direct regulation of intestinal fate by Notch. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Nadin,et al. Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-l-alaninamide] , 2005, Journal of Pharmacology and Experimental Therapeutics.
[4] Sanjiv S Gambhir,et al. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. , 2005, Analytical chemistry.
[5] W. Pear,et al. Notch and the immune system. , 2003, Immunity.
[6] A. Hofman,et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.
[7] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[8] L. Beckett,et al. Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.
[9] M. Shearman,et al. Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay , 2000, Journal of Neuroscience Methods.
[10] K. Ashe,et al. Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease , 2000, The Journal of Neuroscience.
[11] D. Dickson,et al. The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.
[12] K. Beyreuther,et al. Generation of βA4 from the amyloid protein precursor and fragments thereof , 1993 .
[13] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[14] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[15] B. Imbimbo. Therapeutic Potential of γ -Secretase Inhibitors and Modulators , 2008 .
[16] D. Beher. γ-Secretase Modulation and its Promise for Alzheimers Disease: a Rationale for Drug Discovery , 2008 .
[17] I. Peretto,et al. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective. , 2008, Current topics in medicinal chemistry.